Companion Growth Leverage Virbac's 61% revenue share from companion animals and strong Q1 2026 growth in this segment to target veterinarians, pet clinics, and pet owner channels with expanded preventive care, diagnostics, and nutrition solutions.

Global Footprint Virbac operates production sites in 12 countries and sales subsidiaries in 36, with nearly 60% of sales outside Europe. Focus regional market entries and partnerships in high-growth outside-Europe markets to accelerate distribution and local regulatory alignment.

R&D Backbone With R&D centers on five continents and notable contributions from Supercharge4 platforms, explore co-development and licensing opportunities for innovative animal health solutions, diagnostics, and digital health tools that complement existing portfolios.

Financial Resilience 2025 annual results show solid revenue growth and a robust EBIT margin; despite isolated production disruptions, there is momentum for price/mix benefits. Target customers with value-based proposals and uptime guarantees to sustain profitability.

Digital Readiness Virbac’s tech stack includes cloud, SCADA, ERP and ecommerce elements; opportunities exist to expand digital ordering, remote monitoring, and data-driven veterinary services through enhanced online platforms and integration with partner systems.